P

Inventor

YUAN SHENDONG

US28 patents
⚠️ This page may combine multiple inventors who share the name “YUAN SHENDONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

8 patents
US6861424B2Mar 1, 2005

Platelet adenosine diphosphate receptor antagonists

SCHERING AG19 citations92
US7504410B2Mar 17, 2009

Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents

SCHERING AG13 citations81
US7026323B2Apr 11, 2006

Platelet adenosine diphosphate receptor antagonists

SCHERING AG8 citations73
US7105563B2Sep 12, 2006

Indolinone derivatives and their use in treating disease-states such as cancer

SCHERING AG10 citations70
US6995156B2Feb 7, 2006

Platelet adenosine diphosphate receptor antagonists

SCHERING AG2 citations62
US7084142B2Aug 1, 2006

Platelet adenosine diphosphate receptor antagonists

SCHERING AG0 citations51
US7056923B2Jun 6, 2006

Platelet adenosine diphosphate receptor antagonists

SCHERING AG0 citations51
US7176207B2Feb 13, 2007

Platelet adenosine diphosphate receptor antagonists

SCHERING AG0 citations49

BLADE THERAPEUTICS INC

4 patents
US10934261B2Mar 2, 2021

Calpain modulators and therapeutic uses thereof

BLADE THERAPEUTICS INC15 citations83
US10590084B2Mar 17, 2020

Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof

BLADE THERAPEUTICS INC20 citations83
US11339130B1May 24, 2022

Calpain modulators and therapeutic uses thereof

BLADE THERAPEUTICS INC0 citations60
US11292801B2Apr 5, 2022

Calpain modulators and therapeutic uses thereof

BLADE THERAPEUTICS INC0 citations49

ZOMAGEN BIOSCIENCES LTD

3 patents
US12466800B2Nov 11, 2025

N-((1,2,3,5,6,7-hexahydro-S-indacen-4-yl)carbamoyl)-4, 5, 6, 7-tetrahydrobenzofuran-2-sulfonamide derivatives and related compounds as NLPR3 modulators for the treatment of multiple sclerosis (MS)

ZOMAGEN BIOSCIENCES LTD0 citations47
US12351564B2Jul 8, 2025

NLRP3 modulators

ZOMAGEN BIOSCIENCES LTD0 citations47
US11603375B2Mar 14, 2023

NLRP3 modulators

ZOMAGEN BIOSCIENCES LTD0 citations47

VENTYX BIOSCIENCES INC

2 patents
US11753411B2Sep 12, 2023

Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands

VENTYX BIOSCIENCES INC1 citations57
US11780842B2Oct 10, 2023

TYK2 pseudokinase ligands

VENTYX BIOSCIENCES INC0 citations46

ESCALIER BIOSCIENCES B V

2 patents
US11242350B2Feb 8, 2022

Spirocyclic ROR-gamma modulators

ESCALIER BIOSCIENCES B V0 citations47
US11230555B2Jan 25, 2022

Bicyclic RORγ modulators

ESCALIER BIOSCIENCES B V0 citations47

VIMALAN BIOSCIENCES INC

2 patents
US11459333B2Oct 4, 2022

Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors

VIMALAN BIOSCIENCES INC0 citations46
US11136329B2Oct 5, 2021

JAK inhibitors

VIMALAN BIOSCIENCES INC0 citations46

ELAN PHARM INC

1 patent
US8367836B2Feb 5, 2013

Pyridinone antagonists of alpha-4 integrins

ELAN PHARM INC8 citations79

SCHERING AKTIENGESELLSHAFT

1 patent
US7528173B2May 5, 2009

Plasma carboxypeptidase B inhibitors

SCHERING AKTIENGESELLSHAFT2 citations56

ADLER MARC

1 patent
US8198456B2Jun 12, 2012

Dihydropyridine derivatives as useful as protein kinase inhibitors

ADLER MARC2 citations53

UNIV CALIFORNIA

1 patent
US11932606B2Mar 19, 2024

Anti-cancer/anti-fibrosis compounds

UNIV CALIFORNIA0 citations50

BAYER SCHERING PHARMA AG

1 patent
US8008325B2Aug 30, 2011

Plasma carboxypeptidase B inhibitors

BAYER SCHERING PHARMA AG0 citations48

MICHELS MARTIN

1 patent
US8759341B2Jun 24, 2014

Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof

MICHELS MARTIN0 citations39

IMAGO PHARMACEUTICALS INC

1 patent
US9493485B2Nov 15, 2016

Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof

IMAGO PHARMACEUTICALS INC0 citations38